Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX | CATALYST PHARMACEUTICALS INC | $2.75B | $23.06 | $32.50 | 40.94% | Strong Buy | 6 | 15.76% | 26.55% | 48.00% | 41.10% | ||||
EXEL | EXELIXIS INC | $9.62B | $33.67 | $36.80 | 9.30% | Buy | 15 | 11.07% | 25.87% | 45.39% | 34.89% | ||||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.21B | $38.78 | $56.00 | 44.40% | Strong Buy | 7 | 21.37% | 39.52% | 67.18% | 43.20% | ||||
CORT | CORCEPT THERAPEUTICS INC | $7.13B | $68.04 | $88.25 | 29.70% | Strong Buy | 4 | 22.70% | 43.53% | 79.63% | 64.86% | ||||
RPRX | ROYALTY PHARMA PLC | $18.50B | $31.40 | $45.50 | 44.90% | Strong Buy | 2 | 30.86% | 69.55% | 27.57% | 15.67% | ||||
HALO | HALOZYME THERAPEUTICS INC | $7.37B | $57.94 | $62.38 | 7.65% | Buy | 8 | 22.21% | 38.18% | 250.55% | 53.55% | ||||
KRYS | KRYSTAL BIOTECH INC | $4.63B | $161.06 | $213.00 | 32.25% | Buy | 5 | 49.80% | 74.28% | 31.69% | 28.58% | ||||
ADMA | ADMA BIOLOGICS INC | $4.00B | $16.92 | $23.67 | 39.88% | Strong Buy | 3 | 22.90% | 53.60% | 137.62% | 81.70% | ||||
GMAB | GENMAB A | $12.80B | $19.35 | $44.75 | 131.27% | Buy | 4 | 21.21% | 41.53% | 5.49% | 4.42% | ||||
ACAD | ACADIA PHARMACEUTICALS INC | $3.18B | $19.13 | $24.38 | 27.42% | Buy | 8 | 11.71% | 37.49% | 69.38% | 40.99% | ||||
SRPT | SAREPTA THERAPEUTICS INC | $10.71B | $112.11 | $159.54 | 42.30% | Buy | 13 | 40.68% | 122.22% | 149.88% | 50.84% | ||||
BMRN | BIOMARIN PHARMACEUTICAL INC | $12.26B | $64.34 | $91.78 | 42.65% | Strong Buy | 18 | 11.07% | 49.35% | N/A | N/A | ||||
UTHR | UNITED THERAPEUTICS CORP | $15.79B | $353.75 | $417.56 | 18.04% | Strong Buy | 9 | 9.45% | 6.79% | 27.02% | 23.14% | ||||
LGND | LIGAND PHARMACEUTICALS INC | $2.23B | $117.84 | $148.40 | 25.93% | Strong Buy | 5 | 19.60% | 25.10% | 12.00% | 10.57% | ||||
VCEL | VERICEL CORP | $2.95B | $59.70 | $64.17 | 7.48% | Strong Buy | 6 | 28.06% | 163.52% | 36.52% | 24.08% | ||||
GNFT | GENFIT SA | $199.38M | $4.00 | $13.00 | 225.41% | Buy | 1 | 25.32% | -54.80% | -40.58% | -20.29% | ||||
AGIO | AGIOS PHARMACEUTICALS INC | $1.96B | $34.42 | $59.75 | 73.59% | Buy | 4 | 124.82% | N/A | 3.65% | 3.31% | ||||
REGN | REGENERON PHARMACEUTICALS INC | $78.94B | $722.07 | $944.32 | 30.78% | Buy | 19 | 6.08% | 11.19% | 22.23% | 17.28% | ||||
DNTH | DIANTHUS THERAPEUTICS INC | $679.55M | $22.96 | $46.00 | 100.35% | Buy | 4 | 67.58% | N/A | -23.42% | -22.34% | ||||
KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $1.46B | $20.29 | $38.33 | 88.93% | Strong Buy | 3 | 28.76% | N/A | 27.59% | 21.71% | ||||
NVO | NOVO NORDISK A S | $389.21B | $87.17 | $132.50 | 52.00% | Strong Buy | 2 | 15.54% | 18.69% | 127.00% | 39.12% | ||||
PBYI | PUMA BIOTECHNOLOGY INC | $141.86M | $2.89 | $7.00 | 142.21% | Buy | 1 | -4.97% | -20.83% | 33.49% | 10.79% | ||||
INCY | INCYTE CORP | $14.44B | $74.95 | $76.00 | 1.40% | Buy | 13 | 11.20% | 267.39% | 60.72% | 38.42% | ||||
CDXC | CHROMADEX CORP | $434.62M | $5.69 | $8.00 | 40.60% | Strong Buy | 2 | 31.78% | 1,100.00% | 37.78% | 22.97% | ||||
ROIV | ROIVANT SCIENCES LTD | $7.91B | $10.87 | $15.25 | 40.29% | Buy | 2 | -22.82% | N/A | N/A | N/A | ||||
CVAC | CUREVAC NV | $836.78M | $3.73 | $16.00 | 328.95% | Buy | 1 | -28.46% | -7.30% | 7.27% | 6.17% | ||||
TRDA | ENTRADA THERAPEUTICS INC | $504.42M | $13.48 | $25.67 | 90.41% | Strong Buy | 3 | 11.08% | N/A | 41.54% | 31.64% | ||||
MDXG | MIMEDX GROUP INC | $1.25B | $8.50 | N/A | N/A | N/A | N/A | 12.98% | 3.62% | N/A | N/A | ||||
DTIL | PRECISION BIOSCIENCES INC | $37.43M | $4.88 | $47.00 | 863.11% | Buy | 2 | 1.12% | 23.93% | 4.73% | 2.00% | ||||
KPRX | KIORA PHARMACEUTICALS INC | $11.07M | $3.69 | $10.00 | 171.00% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
JAZZ | JAZZ PHARMACEUTICALS PLC | $7.26B | $120.07 | $179.00 | 49.08% | Strong Buy | 7 | 7.08% | 34.56% | N/A | N/A | ||||
PTGX | PROTAGONIST THERAPEUTICS INC | $2.25B | $37.75 | $55.86 | 47.97% | Strong Buy | 7 | -23.36% | N/A | 16.27% | 14.34% | ||||
VYNE | VYNE THERAPEUTICS INC | $35.70M | $2.42 | $6.88 | 184.09% | Strong Buy | 2 | 332.24% | N/A | -38.31% | -31.94% | ||||
FULC | FULCRUM THERAPEUTICS INC | $206.59M | $3.83 | $3.40 | -11.23% | Hold | 5 | 24.59% | N/A | -17.61% | -16.24% | ||||
VTGN | VISTAGEN THERAPEUTICS INC | $79.91M | $2.87 | N/A | N/A | N/A | N/A | 68.28% | N/A | -73.07% | -66.28% | ||||
TGTX | TG THERAPEUTICS INC | $5.21B | $33.50 | $40.80 | 21.79% | Strong Buy | 5 | 54.04% | N/A | 311.89% | 102.27% | ||||
APRE | APREA THERAPEUTICS INC | $21.60M | $3.98 | $15.50 | 289.94% | Buy | 2 | 11.15% | N/A | -12.63% | -10.31% | ||||
RIGL | RIGEL PHARMACEUTICALS INC | $429.63M | $24.39 | $34.80 | 42.68% | Buy | 5 | 17.15% | 111.84% | -349.03% | 36.64% | ||||
AXSM | AXSOME THERAPEUTICS INC | $5.31B | $109.50 | $144.56 | 32.01% | Strong Buy | 9 | 57.53% | N/A | 738.52% | 122.19% | ||||
VRDN | VIRIDIAN THERAPEUTICS INC | $1.47B | $18.51 | $38.00 | 105.29% | Buy | 7 | 907.34% | N/A | 28.02% | 25.68% | ||||
IRD | OPUS GENETICS INC | $38.51M | $1.22 | $9.00 | 637.70% | Strong Buy | 2 | 65.55% | N/A | -21.17% | -17.98% | ||||
CRSP | CRISPR THERAPEUTICS AG | $3.47B | $40.61 | $77.75 | 91.46% | Buy | 8 | 139.71% | N/A | 46.42% | 39.91% | ||||
VYGR | VOYAGER THERAPEUTICS INC | $305.90M | $5.60 | $13.96 | 149.20% | Strong Buy | 6 | -15.21% | N/A | -0.12% | -0.10% | ||||
ARGX | ARGENX SE | $39.34B | $657.97 | $684.21 | 3.99% | Strong Buy | 14 | 427.28% | N/A | 51.71% | 45.95% | ||||
CAPR | CAPRICOR THERAPEUTICS INC | $651.58M | $14.33 | $41.67 | 190.77% | Strong Buy | 6 | 85.22% | N/A | 296.41% | 217.68% | ||||
ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $468.34M | $17.29 | $58.00 | 235.45% | Strong Buy | 3 | 62.21% | N/A | 132.33% | 93.49% | ||||
SPRO | SPERO THERAPEUTICS INC | $47.05M | $0.86 | $5.00 | 479.37% | Buy | 2 | -43.64% | N/A | 147.31% | 71.39% | ||||
IFRX | INFLARX NV | $149.56M | $2.54 | $8.00 | 214.96% | Buy | 1 | 795.38% | N/A | 84.72% | 69.41% | ||||
BRTX | BIORESTORATIVE THERAPIES INC | $17.23M | $2.49 | $18.00 | 622.89% | Strong Buy | 1 | 494.43% | N/A | 373.98% | 256.41% | ||||
ALT | ALTIMMUNE INC | $491.47M | $6.91 | $19.00 | 174.96% | Strong Buy | 4 | 938.40% | N/A | 99.05% | 89.35% | ||||
STTK | SHATTUCK LABS INC | $59.20M | $1.24 | $8.67 | 598.95% | Hold | 3 | 72.24% | N/A | -50.91% | -44.01% | ||||
CMPX | COMPASS THERAPEUTICS INC | $481.56M | $3.50 | $13.75 | 292.86% | Strong Buy | 4 | 502.15% | N/A | 75.95% | 70.48% | ||||
OCUL | OCULAR THERAPEUTIX INC | $1.20B | $7.64 | $18.00 | 135.60% | Buy | 3 | 34.98% | N/A | -2.83% | -2.03% | ||||
CMRX | CHIMERIX INC | $370.54M | $4.12 | $8.50 | 106.31% | Buy | 2 | 820.67% | N/A | 49.35% | 42.23% | ||||
CLDX | CELLDEX THERAPEUTICS INC | $1.55B | $23.29 | $58.33 | 150.46% | Buy | 6 | 74.17% | N/A | 3.71% | 3.55% | ||||
LEGN | LEGEND BIOTECH CORP | $6.62B | $36.11 | $80.33 | 122.47% | Strong Buy | 6 | 60.36% | N/A | 174.88% | 112.45% | ||||
EPIX | ESSA PHARMA INC | $75.46M | $1.70 | $2.00 | 17.65% | Hold | 1 | N/A | N/A | 62.94% | 61.21% | ||||
PRTA | PROTHENA CORP PUBLIC LTD CO | $777.00M | $14.44 | $39.20 | 171.47% | Buy | 5 | 35.17% | N/A | 37.12% | 33.33% | ||||
BCYC | BICYCLE THERAPEUTICS PLC | $870.67M | $12.61 | $29.43 | 133.38% | Buy | 7 | 29.23% | N/A | -16.01% | -13.35% | ||||
ORMP | ORAMED PHARMACEUTICALS INC | $89.09M | $2.21 | N/A | N/A | N/A | N/A | N/A | N/A | -4.90% | -4.64% | ||||
JANX | JANUX THERAPEUTICS INC | $2.13B | $40.68 | $97.29 | 139.15% | Strong Buy | 7 | 196.07% | N/A | -24.94% | -23.54% | ||||
CGON | CG ONCOLOGY INC | $2.03B | $30.03 | $67.67 | 125.33% | Strong Buy | 6 | 473.41% | N/A | 4.91% | 4.77% | ||||
ZVRA | ZEVRA THERAPEUTICS INC | $420.60M | $7.88 | $21.20 | 169.04% | Strong Buy | 5 | 112.22% | N/A | 166.78% | 60.75% | ||||
QSI | QUANTUM-SI INC | $271.15M | $1.90 | $3.25 | 71.05% | Buy | 2 | 202.72% | N/A | -14.91% | -13.28% | ||||
AUPH | AURINIA PHARMACEUTICALS INC | $1.16B | $8.09 | $11.50 | 42.15% | Strong Buy | 2 | 28.28% | N/A | 54.61% | 38.57% | ||||
TARS | TARSUS PHARMACEUTICALS INC | $2.04B | $53.32 | $58.33 | 9.40% | Buy | 3 | 71.50% | N/A | 86.76% | 54.76% | ||||
CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $42.56M | $3.72 | $12.50 | 236.38% | Strong Buy | 2 | 257.86% | N/A | 34.53% | 26.03% | ||||
IOVA | IOVANCE BIOTHERAPEUTICS INC | $1.79B | $5.88 | $18.83 | 220.29% | Buy | 3 | 120.31% | N/A | 43.54% | 33.98% | ||||
PMCB | PHARMACYTE BIOTECH INC | $11.08M | $1.59 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
AUTL | AUTOLUS THERAPEUTICS PLC | $558.86M | $2.10 | $10.20 | 385.71% | Strong Buy | 3 | 218.10% | N/A | 25.81% | 14.88% | ||||
FOLD | AMICUS THERAPEUTICS INC | $2.94B | $9.83 | $17.00 | 72.94% | Strong Buy | 7 | 22.91% | N/A | 125.32% | 28.49% | ||||
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.45B | $12.42 | $18.50 | 48.95% | Strong Buy | 4 | 50.20% | N/A | 83.31% | 29.84% | ||||
ARDX | ARDELYX INC | $1.34B | $5.67 | $7.88 | 38.89% | Buy | 4 | 32.50% | N/A | 142.89% | 61.49% | ||||
CRGX | CARGO THERAPEUTICS INC | $170.30M | $3.70 | $15.00 | 305.41% | Buy | 5 | N/A | N/A | -28.82% | -25.62% | ||||
RYTM | RHYTHM PHARMACEUTICALS INC | $3.69B | $60.01 | $68.56 | 14.24% | Strong Buy | 9 | 70.08% | N/A | 2,868.34% | 88.48% | ||||
KRON | KRONOS BIO INC | $59.74M | $0.99 | $1.63 | 64.14% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
TSHA | TAYSHA GENE THERAPIES INC | $340.21M | $1.66 | $6.60 | 297.59% | Strong Buy | 5 | 56.92% | N/A | -4.62% | -2.27% | ||||
URGN | UROGEN PHARMA LTD | $462.08M | $10.95 | $42.25 | 285.84% | Strong Buy | 4 | 73.21% | N/A | 778.99% | 65.83% | ||||
TECH | BIO-TECHNE CORP | $11.86B | $75.01 | $87.80 | 17.05% | Buy | 5 | 6.20% | 41.84% | N/A | N/A | ||||
SNDX | SYNDAX PHARMACEUTICALS INC | $1.35B | $15.82 | $36.11 | 128.26% | Strong Buy | 9 | 184.88% | N/A | 11.88% | 10.22% | ||||
FENC | FENNEC PHARMACEUTICALS INC | $182.70M | $6.66 | $14.00 | 110.21% | Buy | 2 | 46.50% | N/A | -1,347.47% | 118.26% | ||||
CRVO | CERVOMED INC | $18.41M | $2.23 | $37.60 | 1,586.10% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
STOK | STOKE THERAPEUTICS INC | $674.80M | $12.74 | $27.00 | 111.93% | Strong Buy | 3 | 74.17% | N/A | -38.03% | -30.10% | ||||
NTLA | INTELLIA THERAPEUTICS INC | $1.03B | $10.13 | $44.93 | 343.56% | Buy | 15 | 141.95% | N/A | 66.59% | 54.63% | ||||
MNKD | MANNKIND CORP | $1.56B | $5.65 | $9.75 | 72.57% | Strong Buy | 4 | 18.31% | 56.56% | -56.49% | 25.55% | ||||
CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | $6.21M | $3.55 | N/A | N/A | N/A | N/A | 1,383.34% | N/A | 169.06% | 160.93% | ||||
MIRM | MIRUM PHARMACEUTICALS INC | $2.46B | $51.23 | $59.83 | 16.79% | Strong Buy | 6 | 34.21% | N/A | 133.65% | 46.43% | ||||
SKYE | SKYE BIOSCIENCE INC | $90.41M | $2.98 | $17.25 | 478.86% | Strong Buy | 4 | N/A | N/A | -91.65% | -85.21% | ||||
GNLX | GENELUX CORP | $153.00M | $4.43 | $16.00 | 261.17% | Strong Buy | 3 | 2,691.47% | N/A | 89.76% | 73.76% | ||||
VALN | VALNEVA SE | $481.33M | $6.93 | $18.00 | 159.74% | Buy | 1 | 38.12% | N/A | 118.22% | 49.76% | ||||
NTRB | NUTRIBAND INC | $74.08M | $6.67 | $13.00 | 94.90% | Buy | 1 | 346.36% | N/A | 361.91% | 324.07% | ||||
ABVX | ABIVAX SA | $379.17M | $6.03 | $33.00 | 447.72% | Buy | 2 | 94.03% | N/A | -124.98% | -55.56% | ||||
SXTP | 60 DEGREES PHARMACEUTICALS INC | $1.22M | $0.53 | N/A | N/A | N/A | N/A | 60.62% | N/A | -11.03% | -8.98% | ||||
MDGL | MADRIGAL PHARMACEUTICALS INC | $7.20B | $330.27 | $369.29 | 11.81% | Buy | 7 | 182.80% | N/A | 130.20% | 94.28% | ||||
PHAR | PHARMING GROUP NV | $601.70M | $8.87 | $27.00 | 204.40% | Strong Buy | 3 | 12.40% | N/A | 55.88% | 29.65% | ||||
SPRY | ARS PHARMACEUTICALS INC | $1.24B | $12.80 | $28.33 | 121.35% | Strong Buy | 3 | 377.51% | N/A | 79.06% | 73.02% | ||||
RVMD | REVOLUTION MEDICINES INC | $7.33B | $43.57 | $70.20 | 61.12% | Strong Buy | 10 | 474.74% | N/A | -22.73% | -20.19% | ||||
APLS | APELLIS PHARMACEUTICALS INC | $3.76B | $30.20 | $44.63 | 47.76% | Buy | 16 | 19.92% | N/A | 151.52% | 39.84% | ||||
GLYC | GLYCOMIMETICS INC | $17.54M | $0.27 | N/A | N/A | N/A | N/A | 844.76% | N/A | -22.67% | -16.43% | ||||
SWTX | SPRINGWORKS THERAPEUTICS INC | $2.92B | $39.28 | $70.00 | 78.21% | Strong Buy | 4 | 84.73% | N/A | 63.13% | 55.22% |